University of Illinois: Exploring Innovative Cell Engineering Methods Seminar

Webinars & Presentations University of Illinois: Exploring Innovative Cell Engineering Methods Seminar

Join us for a Seminar on Exploring Innovative Cell Engineering Methods: Insights from MaxCyte at University of Illinois

Join us live from University of Illinois for a seminar: Exploring Innovative Cell Engineering Methods

Monday, June 24, 2024
12:30 PM - 1:30 PM (CT)

In-person
University of Illinois, Chicago
900 South Ashland Ave.
MBRB 1009
Chicago, IL 60607

About the event

MaxCyte is hosting a cell engineering seminar on Monday, June 24 at 12:30 pm (CT) at the University of Illinois - Chicago.

Register to hear how guest speaker Vimal Keerthi uses MaxCyte's scalable transfection platforms to engineer primary cells, stem cells, and other hard-to-transfect cell lines while maintaining high efficiency and viability regardless of application. Dan Miller and Victoria Zellmer from the MaxCyte Field Team will be onsite to further discuss your applications.

Lunch on us: we value your time, and to keep the focus on learning, we're providing a complimentary lunch for all attendees.

Hosts

Vimal Keerthi

Process Development Scientist
Dr. Steven Feldman’s Lab Stanford Laboratory of Cell and Gene Medicine Stanford Center for Cancer

Vimal is a Process Development Scientist in Dr. Steven Feldman’s group at the Stanford Center for Cancer Cell Therapy focusing on developing CRISPR knock-in platforms for non-viral CAR-T manufacturing. Prior to working on non-viral platforms, Vimal worked on the process development of Allogeneic Hematopoietic Stem Cell Transplants and donor derived T-allo10 Tr1 cell therapies at Stanford’s cGMP Laboratory of Cell & Gene Medicine.

Dan Miller, MS

Field Application Scientist
MaxCyte, Inc.

Dan Miller is the MaxCyte Field Application Scientist for the Central US. Dan earned his Master's in Cellular and Molecular Biology at Missouri University of Science and Technology. He started his professional career at Sigma Aldrich on the CHOZN team where he engineered a CHO KO line resistant to MVM infection. After completion of this project, he moved to the custom services team generating KO and KI cell lines for customers in the CHOZN platform. He next joined M6P Therapeutics where he continued to do high throughput cell line development before joining MaxCyte in 2022.

Victoria Zellmer, PhD

Sales Manager
MaxCyte, Inc.

Victoria Zellmer is the MaxCyte Sales Manager for the Central US. Victoria earned her Ph.D. in Biological Sciences at the University of Notre Dame where she studied the tumor microenvironment in a breast cancer context. Victoria has spent the past several years serving her customers with her experience in cellular & molecular biology, assay development, genome editing, and various animal models.